Compassionate Cancer Care Medical Group

Fountain Valley, California 92708

1 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Anal Cancer, Anal Neoplasm, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer, Androgen-Resistant Prostatic Cancer, B-Cell Lymphomas, Cachexia, Carcinoma, Squamous Cell of Head and Neck, Castration-Resistant Prostatic Cancer, FGFR Mutations, FGFR Translocations

Studies at this site

• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors — Stopped early
• Long-term Registry of Patients Treated With Loncastuximab Tesirine — Withdrawn before enrolling
• Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208) — Stopped early
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. — Completed